ArticleMikrochimica acta2026
An intelligent signal processing strategy for accurate quantification of composite signals in background fluorescence-quenching lateral flow immunoassay for folic acid.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background fluorescence-quenching lateral flow immunoassay (BF-LFIA) holds great potential for high-sensitivity detection owing to its unique “turn-on” mechanism. However, its characteristic composite signals, comprising “quenched dark zones” and “fluorescent bright zones,” exhibit high heterogeneity and dynamic evolution, severely restricting the accuracy and universality of automated quantification. To overcome this challenge, a portable analysis system was constructed and a dedicated intelligent image analysis framework is proposed. This framework integrates three core algorithm modules: (1) Synergistic Color-Space Segmentation (SCSS), which leverages the complementary advantages of HSV and CIELAB spaces to achieve robust extraction of fluorescent signal regions; (2) Adaptive Spatial Localization (ASL), which employs pixel density projection and spatial constraint mechanisms to precisely lock onto the regions of interest (ROI) for Test (T) and Control (C) lines; and (3) Adaptive Fusion Quantification (AFQ), which integrates multi-dimensional color features via a dynamic weight allocation mechanism. Validated by a Random Forest model with 5-fold cross-validation, the AFQ algorithm demonstrated robustness in the precise resolution of composite signals. Using folic acid (FA) as the analyte, the system achieved ultrasensitive quantitative detection within the 0–300 ng/mL range. The concentration-response curve, fitted by a four-parameter logistic model, exhibited excellent linearity (R2 = 0.9996). The proposed strategy effectively resolves the quantification challenge of composite signals in BF-LFIA platforms, providing a powerful tool for high-performance point-of-care testing (POCT) and offering a general methodological reference for other biomarker detections based on background fluorescence-quenching mechanisms.
Indexed as
Identifiers
41764116What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.